# Alogliptin

## NESINA 25mg

| TAH Drug Code      | [ONES](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=ONES                                                                                                                                                                                                                        |
|:-------------------|:-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Diabetes mellitus, type 2                                                                                                                                                                                                                                                                  |
| Dosing             | 25 mg once daily.                                                                                                                                                                                                                                                                          |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                              |
| Renal Impairment   | Dose adjustment required                                                                                                                                                                                                                                                                   |
| Contraindications  | History of serious hypersensitivity (eg, anaphylaxis, angioedema, severe cutaneous reactions) to alogliptin or any component of the formulation.                                                                                                                                           |
| Adverse Effects    | Common: Headache (4.3%), Nasopharyngitis (4.8%), Upper respiratory infection (4.5%) Serious: Congestive heart failure, Bullous pemphigoid, Stevens-Johnson syndrome, Pancreatitis, acute (0.2%), Fulminant hepatic failure, Anaphylaxis, Hypersensitivity reaction, Arthralgia, Angioedema |
| Pregnancy          | No (Limited) Human Data â€“ Animal Data Suggest Low Risk                                                                                                                                                                                                                                     |
| Lactation          | No (Limited) Human Data - Probably Compatible                                                                                                                                                                                                                                              |
| More Info          | [UpToDate](https://www.uptodate.com/contents/alogliptin-drug-information)                                                                                                                                                                                                                  |

